GLOX THERAPEUTICS LIMITED
🌿Early-stageactive
SC760230 · ltd · incorporated 2023-02-27
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
—
Upgrade to see
Turnover
—
not disclosed
Net worth
—
book net assets
Opportunity
72/100
Strong
What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
ALSO REGISTERED FOR
- 72190Other research and experimental development on natural sciences and engineering
Investor take
PursueStrong opportunity: active trading company with strong profile and acceptable with review structure.
Opportunity 72/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).
Data confidence
Overall: medium (57/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 2 SIC codes, incorporation date
100
Financials
No iXBRL financials extracted
0
Lenders & charges
Confirmed no charges registered
85
Directors & officers
7 officers (3 active, 7 linked, 6 with DOB)
87
Ownership & PSC
0 active PSC(s) of 3 total, 3 with control declared
90
Director network
4 connected companies via shared directors
57
Filing history
31 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
72/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
60
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
77
Few red flags.
Signal strength
90
Good data coverage for analysis.
Recent activity
Last 30 days
0
filings
Last 90 days
1
filing
- • 1 confirmation-statement
Last 180 days
4
filings
- • 3 officers
- • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (34 events)Click to expand
- 2025-11-06📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-11-06📄termination-director-company-with-name-termination-dateofficers · TM01
- 2025-11-06📄termination-director-company-with-name-termination-dateofficers · TM01
- 2025-09-26➖CLARK, James Scott, Dr resigneddirector
- 2025-09-12📄accounts-with-accounts-type-smallaccounts · AA
- 2025-08-12➕NICKLIN, Paul, Dr appointeddirector
- 2025-08-12➖CZELOTH, Niklas, Dr resigneddirector
- 2025-07-21📄capital-allotment-sharescapital · SH01
- 2025-07-18📄termination-secretary-company-with-name-termination-dateofficers · TM02
- 2025-05-14➖BARCLAY, Patricia Barbara Ann resignedsecretary
- 2025-02-06➕MURRAY, Michael Stephen, Dr appointeddirector
- 2025-02-06📄appoint-person-director-company-with-name-dateofficers · AP01
- 2024-11-20📄notification-of-a-person-with-significant-control-statementpersons-with-significant-control · PSC08
- 2024-09-17📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-08-19➖ANDERSON, Melville resigneddirector
- 2024-08-19📄termination-director-company-with-name-termination-dateofficers · TM01
- 2024-08-08📄accounts-with-accounts-type-smallaccounts · AA
- 2024-02-20📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2024-01-18📄appoint-person-director-company-with-name-dateofficers · AP01
- 2024-01-18📄appoint-person-director-company-with-name-dateofficers · AP01
- 2024-01-17📄capital-allotment-sharescapital · SH01
- 2024-01-17📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2024-01-09📄resolutionresolution · RESOLUTIONS
- 2024-01-09📄memorandum-articlesincorporation · MA
- 2023-10-24➕WALKER, Daniel, Professor appointeddirector
- 2023-10-24➕CZELOTH, Niklas, Dr appointeddirector
- 2023-05-16📄resolutionresolution · RESOLUTIONS
- 2023-05-16📄memorandum-articlesincorporation · MA
- 2023-05-16📄resolutionresolution · RESOLUTIONS
- 2023-05-15📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2023-02-27🏢Company incorporatedAs GLOX THERAPEUTICS LIMITED
- 2023-02-27➕BARCLAY, Patricia Barbara Ann appointedsecretary
- 2023-02-27➕ANDERSON, Melville appointeddirector
- 2023-02-27➕CLARK, James Scott, Dr appointeddirector
Owner dependency
58/100
Moderate — manageable with handoverSome founder dependency, but not acute. A structured handover period should cover most risk.
FACTORS
- +Senior director age: Director aged approximately 63 — approaching natural succession window.
Succession & seller-readiness
50/100
Moderate signalSome succession indicators present. Worth watching; approach if sector/strategy fits.
SIGNALS
- primaryFounder aged 63+: Senior director is approximately 63. Approaching typical UK retirement age — succession thinking likely.
Red flags
1 med ·3 director resignations in last 12 months
mediumMultiple recent departures can indicate governance disagreement, succession event, or preparation for sale/stress.
Evidence: BARCLAY, Patricia Barbara Ann resigned 2025-05-14; CLARK, James Scott, Dr resigned 2025-09-26; CZELOTH, Niklas, Dr resigned 2025-08-12
🔒Co-director network graph
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Professional services · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| G- PARALEGAL SERVICES FIRM LIMITED→ SC858110 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| GMCG CONSULTANCY LIMITED→ SC836826 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| GMG (HOLDINGS) LIMITED→ SC212170 · est 2000 · no financials extracted | — | — | — | — | 25y | — | — |
| GNB ACQUISITIONS LIMITED→ SC638987 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| GNTAX ACCOUNTING SERVICES LTD→ SC584766 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| GO BE SEARCH LTD→ SC698434 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| GO EXPLORE (SCOTLAND) LIMITED→ SC593975 · est 2018 · no financials extracted | — | — | — | — | 8y | — | — |
| GO GREEN DELIVERIES GROUP LIMITED→ SC733352 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| GOLDEN BOOT AGENCY LIMITED→ SC783030 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| GPC ENGINEERING CONSULTANCY LTD→ SC836013 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| GPFUSION LTD→ SC834383 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| GR23 CONSULTANCY LTD→ SC859559 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2023-02-27
Jurisdictionscotland
Primary SIC72110 — Research and experimental development on biotechnology
Registered office
John Arbuthnott Building Strathclyde University Of Pharmacy & Biomedical
161 Cathedral Street
Glasgow
G4 0RE
Scotland
Filing status
Accounts
Next due: 2026-09-30
Last made up to: 2024-12-31
Confirmation statement
Next due: 2027-03-12
Last: 2026-02-26
Officers (3 active · 4 resigned)
MURRAY, Michael Stephen, Dr→
Activedirector · ~63y · appointed 2025-02-06
View their other companies + combined net worth →
NICKLIN, Paul, Dr→
Activedirector · ~59y · appointed 2025-08-12
View their other companies + combined net worth →
WALKER, Daniel, Professor→
Activedirector · ~53y · appointed 2023-10-24
View their other companies + combined net worth →
BARCLAY, Patricia Barbara Ann→
Resignedsecretary · appointed 2023-02-27 · resigned 2025-05-14
ANDERSON, Melville→
Resigneddirector · ~61y · appointed 2023-02-27 · resigned 2024-08-19
CLARK, James Scott, Dr→
Resigneddirector · ~58y · appointed 2023-02-27 · resigned 2025-09-26
CZELOTH, Niklas, Dr→
Resigneddirector · ~50y · appointed 2023-10-24 · resigned 2025-08-12
Click a director name to see their full track record across all companies.
Recent filings (31 total)
confirmation-statement-with-updates
confirmation-statement · CS01
2026-03-26
appoint-person-director-company-with-name-date
officers · AP01
2025-11-06
termination-director-company-with-name-termination-date
officers · TM01
2025-11-06
termination-director-company-with-name-termination-date
officers · TM01
2025-11-06
accounts-with-accounts-type-small
accounts · AA
2025-09-12
capital-allotment-shares
capital · SH01
2025-07-21
termination-secretary-company-with-name-termination-date
officers · TM02
2025-07-18
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-03-26
appoint-person-director-company-with-name-date
officers · AP01
2025-02-06
notification-of-a-person-with-significant-control-statement
persons-with-significant-control · PSC08
2024-11-20
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2024-09-17
termination-director-company-with-name-termination-date
officers · TM01
2024-08-19
accounts-with-accounts-type-small
accounts · AA
2024-08-08
confirmation-statement-with-updates
confirmation-statement · CS01
2024-03-22
change-account-reference-date-company-previous-shortened
accounts · AA01
2024-02-20